Cardio Diagnostics Holdings Inc. Common stock Share Price
CDIOCardio Diagnostics Holdings Inc. Common stock Stock Performance
Open $2.04 | Prev. Close $2.01 | Circuit Range N/A |
Day Range $2.04 - $2.08 | Year Range $0.97 - $7.89 | Volume 315 |
Average Traded $2.06 |
Cardio Diagnostics Holdings Inc. Common stock Share Price Chart
About Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, including concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
Cardio Diagnostics Holdings Inc. Common stock Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
29-Jun-26 | $2.04 | $2.08 | +0.00% |
29-Jun-26 | $2.04 | $2.08 | +2.97% |
26-Jun-26 | $2.02 | $2.02 | +0.00% |
24-Jun-26 | $2.02 | $2.02 | -6.05% |
23-Jun-26 | $2.02 | $2.15 | +5.96% |
22-Jun-26 | $1.97 | $2.03 | +1.45% |
18-Jun-26 | $2.08 | $2.00 | -2.91% |